About Neotract
Neotract is a company based in Mountain View (United States) founded in 2004 was acquired by Teleflex Medical in September 2017. Neotract has raised $137.96 million across 9 funding rounds from investors including Teleflex Medical, CRG and Johnson & Johnson Innovation – JJDC. The company has 119 employees as of December 31, 2015. Neotract offers products and services including Support Center, NS Lookup Tool, Web Browser Details Checker, Site Down Checker, and IP Address Checker. Neotract operates in a competitive market with competitors including Zenflow, Urotronic, Butterfly Medical, Rivermark and ProVerum Medical, among others.
- Headquarter Mountain View, United States
- Employees 119 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neotract Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$137.96 M (USD)
in 9 rounds
-
Latest Funding Round
$12.82 M (USD), Series C
Jan 06, 2017
-
Investors
Teleflex Medical
& 4 more
-
Employee Count
119
as on Dec 31, 2015
-
Acquired by
Teleflex Medical
(Sep 05, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neotract
Neotract offers a comprehensive portfolio of products and services, including Support Center, NS Lookup Tool, Web Browser Details Checker, Site Down Checker, and IP Address Checker.
Platform for submitting and managing support requests
Tool to check domain name system records online
Utility to verify web browser configurations
Service to test if a website is accessible
Tool to display and analyze user IP addresses
Funding Insights of Neotract
Neotract has successfully raised a total of $137.96M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $12.82 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neotract
Neotract has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Teleflex Medical, CRG and Johnson & Johnson Innovation – JJDC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRG is recognized as a premier healthcare investment partner.
|
Locked | Locked | Locked | |
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked |
Investor details for Neotract
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neotract
Investment portfolio details for Neotract
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neotract
Detailed financials for Neotract
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neotract Comparisons
Peer comparison for Neotract
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neotract
Neotract operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zenflow, Urotronic, Butterfly Medical, Rivermark and ProVerum Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A device is developed to treat urinary obstruction from BPH.
|
|
| Locked | Locked | Locked |
Urethral stricture treatment devices are developed by Urotronic.
|
|
| Locked | Locked | Locked |
Developer of an implantable device for the treatment of benign prostatic hyperplasia (BPH)
|
|
| Locked | Locked | Locked |
Medical device for benign prostatic hyperplasia treatment is developed.
|
|
| Locked | Locked | Locked |
Developer of a minimally-invasive medical device for benign prostatic hyperplasia
|
Detailed competitors of Neotract
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neotract
Complete news archive for Neotract
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neotract
Neotract was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Neotract is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Neotract is a funded company, having raised a total of $137.96M across 9 funding rounds to date.
As of Dec 31, 2015, the latest employee count at Neotract is 119.
NeoTract develops surgical devices for urological disorders. The first product is UroLift, a minimally invasive device to treat lower urinary tract symptoms due to Benign Prostatic Hyperplasia (BPH). The permanent UroLift implant is placed transurethrally. It lifts the enlarged prostate tissue out of the way so it no longer blocks the urethra.
Neotract offers Support Center, NS Lookup Tool, Web Browser Details Checker, Site Down Checker, and IP Address Checker.
Neotract has 5 investors. Key investors include Teleflex Medical, CRG, Johnson & Johnson Innovation – JJDC, NEA, and Quilvest Private Equity.